Enter your terms above and click the 'Search' button.

Showing articles 0 to 9 of 9 Filter Applied: cerebrovascular accident,cryptogenic (Click to remove) Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence Stroke 55:236-247, Sposato,L.A.,et al, 2024 Feasibility and Diagnostic Value of Cardiovascular Magnetic Resonance Imaging after Acute Ischemic Stroke of Undetermined Origin Stroke 48:1241-1247, Haeusler, K.G.,et al, 2017 Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017 Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke NEJM 377:1033-1042,1006,1093, Sondergaard, L.,et al, 2017 Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia NEJM 371:699-710, DeBaun, M.R.,et al, 2014 Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013 Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism NEJM 368:1083-1091,1152, Meier, B.,et al, 2013 Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012 Patent Foramen Ovale Closure Devices JAMA 294:366-369, Maisel,W.H.&Laskey,W.K., 2005 Showing articles 0 to 9 of 9